SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001636050-20-000072
Filing Date
2020-11-10
Accepted
2020-11-10 17:10:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-4/A agtlforms-4ax1.htm S-4/A 2307245
2 EX-23.1 s4a1exhibit231.htm EX-23.1 3032
3 GRAPHIC alpd1.jpg GRAPHIC 44055
  Complete submission text file 0001636050-20-000072.txt   2372335
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: S-4/A | Act: 33 | File No.: 333-249279 | Film No.: 201302088
SIC: 2834 Pharmaceutical Preparations